Judith Michels, Medical Oncologist at Gustave Roussy Cancer Center, shared on LinekdIn:
“An immense privilege of getting the vision today at Gustave Roussy of Jedd Wolchok from Weill Cornell Medicine on tumor immunology, one of the true pioneers of immuno-oncology who initiated the rationale and led the first clinical trial combining anti-PD-1 and anti-CTLA-4, a combination that went on to transform the treatment of melanoma and, since then, many other cancers.”
You can also read:
PRINCE Trial: Biomarkers of ¹⁷⁷Lu-PSMA-617 Plus Pembrolizumab in mCRPC
